EQMICRO

Equillium, Inc.

HealthcareBiotechnology
$3.08
$0.00(+0.98%)
52W$0.29
$3.43
Updated Jun 29, 02:00 AM
RSI61
RS Rating95/99
Beta0.37
Volatility164%
F-Score1/9
Mkt Cap$297M
STAGE 2 UPTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

STAGE 2 UPTREND

Equillium, Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 95), indicating clear outperformance against the broad market. Earnings growth of 77% provides fundamental context to the price action. However, price is extended 24% above the 50-day line, increasing the risk of a mean reversion.

Relative Strength
95
out of 99
Market Leader
Trend Score
4/4
Minervini Criteria
STAGE 2 UPTREND
Risk (Beta)
0.37
vs S&P 500
LOW VOL
52W Position
89%
from 52W low
Near High
Trend & Momentum Analysis

Trend Template (Minervini)

STAGE 2 UPTREND4/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$2.48
50 SMA > 100 SMA$2.18
100 SMA > 150 SMA$1.85
150 SMA > 200 SMA$1.73

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$2.90+6.08%ABOVE
50 SMA$2.48+23.95%ABOVE
100 SMA$2.18+41.44%ABOVE
150 SMA$1.85+66.47%ABOVE
200 SMA$1.73+78.28%ABOVE

Price Performance

1D+1.0%
1W+7.7%
1M+6.2%
3M+76.0%
6M+109.5%
YTD+101.3%
1Y+8.8%
3Y+60.1%
52-Week Trading Range89% from low
$3.08
52W Low$0.29
52W High$3.43

Technical Indicators

RSI (14)BULLISH
60.7
305070
Setup ScoreCOOL
5/10
Base depth: 56.3%

Risk Profile

Beta
0.37
52W Vol
164%
ATR
$0.25
Max DD (1Y)
-58%

Volume Analysis

Today
363.1K
50D Avg
549.0K
Vol Ratio
0.66x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25-1350%
$-0.16
Q3'25-59900%
$-0.12
Q4'25+74%
$-0.04
Q1'26+77%
$-0.06
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:-100.00%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+2.87%

Stock Price CAGR

10 Years:-14.05%
5 Years:-11.36%
3 Years:+60.14%
1 Year:+8.77%

Return on Equity

10Y Avg:-63.7%
5Y Avg:-73.1%
3Y Avg:-60.6%
Last Year:-61.4%

Key Metrics

Market Cap$297M
Gross Margin
Net Margin
Piotroski F-Score1/9

Frequently Asked Questions

Is EQ in an uptrend right now?

EQ has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, EQ is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.

Is EQ overbought or oversold?

EQ's RSI (14) is 61. The stock is in neutral territory, neither overbought nor oversold.

Is EQ outperforming the market?

EQ has a Relative Strength (RS) Rating of 95 out of 99. Yes, EQ is a market leader, outperforming 95% of all stocks over the past 12 months.

Where is EQ in its 52-week range?

EQ is trading at $3.08, which is 90% of its 52-week high ($3.43) and 89% above its 52-week low ($0.29).

How volatile is EQ?

EQ has a Beta of 0.37 and 52-week volatility of 164%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.